Category Archives: Genetics

Chief scientist Peter Klinken recognised for work in disease genetics – ABC Online

Posted June 12, 2017 00:16:15

Western Australia's chief scientist Peter Klinken said he was "gobsmacked" when he found he had been made a Companion of the Order of Australia.

Professor Klinken has been recognised for service to medical research and biochemistry through his contributions to understanding the genetics of diseases.

He had also been recognised for promoting science and innovation in WA.

Professor Klinken said the Queen's Birthday honour was unexpected.

"Gobsmacked to be honest, it was just mind-blowing when I got the information. I had to read the letter several times to actually get it to sink in. It is such an honour," he said.

"I didn't go into what I'm doing now with the expectation of receiving accolades, but hopefully what I've done has contributed to the good of our society and I'm just blown away by this honour."

Professor Klinken was born in Singapore, and educated in Perth, where he did a PhD.

He said it was when he went to the United States in the 1980s to do some studies at the National Cancer Institute that he became interested in cancer genetics.

"I spent the vast majority of my scientific career trying to identify these genes that go wrong," he said.

"Working out why they go wrong and how you can try and fix them up in leukaemias and certain cancers."

Professor Klinken said this area of research marked out the achievements he was most proud of.

"Actually identifying that cells, which were apparently committed to one particular function or one job, could actually change their functions change their job description, so to speak," he said.

"At that stage, that was unheard of.

"I was able to introduce a couple of genes into these cells and turn them from what were essentially antibody producing cells into macrophages, which are scavenger cells, and that just broke all the dogma at the time.

"I'm particularly proud of the genes that we've discovered that can go wrong in cases of leukaemias and slowly trying to work out, well, how do they go wrong? What are the steps we can take to try and prevent them from causing cancers and leukaemias?"

After he returned to Perth, Professor Klinken took up a position at RPH, and in 1998 became the director of the WA Institute of Medical Research [later the Harry Perkins Institute of Medical Research].

In 2014, he was asked to be Western Australia's chief scientist.

"It has been a remarkable opportunity, a rare privilege ... to see the breadth and depth and quality of science in Western Australia and play a small role in trying to shape it and explain it to policymakers ... to get them to value science and innovation and how important it is to the state," he said.

"And also to spread the word within the community about how science is such an integral part of our life that we sometimes take it for granted."

Topics: awards-and-prizes, science-awards, perth-6000

Read this article:
Chief scientist Peter Klinken recognised for work in disease genetics - ABC Online

Genetics and archaeogenetics of South Asia – Wikipedia

The study of the genetics and archaeogenetics of the ethnic groups of South Asia aims at uncovering these groups' genetic history. The geographic position of the Indian subcontinent makes its biodiversity important for the study of the early dispersal of anatomically modern humans across Asia.

Studies based on mtDNA variation have reported genetic unity across various Indian subpopulations.[1][2][3][4] Conclusions of studies based on Y Chromosome variation and Autosomal DNA variation have been varied, although many researchers argue that most of the ancestral nodes of the phylogenetic tree of all the mtDNA types originated in the subcontinent. Recent genome studies appear to show that most South Asians are descendants of two major ancestral components, one restricted to South Asia (Ancestral South Indian) and the other component (Ancestral North Indian) more closely related to those in Central Asia, West Asia and Europe.[5][6]

It has been found that the ancestral node of the phylogenetic tree of all the mtDNA types typically found in Central Asia, the West Asia and Europe are also to be found in South Asia at relatively high frequencies. The inferred divergence of this common ancestral node is estimated to have occurred slightly less than 50,000 years ago.[7] In India the major maternal lineages, or mitochondrial DNA haplogroups are M, R and U, whose coalescence times have been approximated to 50,000 BP.[7]

The major paternal lineages represented by Y chromosomes are haplogroups R1a1, R2, H, L and J2.[8] Many Indian researchers have argued that Y-DNA Haplogroup R1a1 (M17) is of autochthonous Indian origin.[9][10] However, proposals for a Central Asian origin for R1a1 are also quite common as it is additionally supported by linguistics and archeology.[11][12]

All the mtDNA and Y-chromosome lineages outside Africa descend from three founder lineages:

All these six founder haplogroups can be found in the present day populations of South Asia. Moreover, the mtDNA haplogroup M and the Y-chromosome haplogroups C and D are restricted to the area east of South Asia. All the West Eurasian populations derive from the N and R haplogroups of mtDNA and the F haplogroup of the Y-chromosome.

Endicott et al. state that these facts are consistent with the hypothesis of a single exodus from East Africa 65,000 years ago via a southern coastal route, with the West Eurasian lineages separating from the South Asian lineages somewhere between East/Northeast Africa and South Asia.

The most frequent mtDNA haplogroups in the Indian subcontinent are M, R and U (where U is a descendant of R).[8]

Arguing for the longer term "rival Y-Chromosome model",[9]Stephen Oppenheimer believes that it is highly suggestive that India is the origin of the Eurasian mtDNA haplogroups which he calls the "Eurasian Eves". According to Oppenheimer it is highly probable that nearly all human maternal lineages in Central Asia, the Middle East and Europe descended from only four mtDNA lines that originated in South Asia 50,000-100,000 years ago.[15]

The macrohaplogroup M which is considered as a cluster of the proto-Asian maternal lineages,[7] represents more than 60% of Indian MtDNA.[16]

The M macrohaplotype in India includes many subgroups that differ profoundly from other sublineages in East Asia especially Mongoloid populations.[7] The deep roots of M phylogeny clearly ascertain the relic of Indian lineages as compared to other M sub lineages (in East Asia and elsewhere) suggesting 'in-situ' origin of these sub-haplogroups in South Asia, most likely in India. These deep rooting lineages are not language specific and spread over all the language groups in India.[16]

Virtually all modern Central Asian MtDNA M lineages seem to belong to the Eastern Eurasian (Mongolian) rather than the Indian subtypes of haplogroup M, which indicates that no large-scale migration from the present Turkic-speaking populations of Central Asia occurred to India. The absence of haplogroup M in Europeans, compared to its equally high frequency among Indians, eastern Asians and in some Central Asian populations contrasts with the Western Eurasian leanings of South Asian paternal lineages.[7]

Most of the extant mtDNA boundaries in South and Southwest Asia were likely shaped during the initial settlement of Eurasia by anatomically modern humans.[17]

The macrohaplogroup R (a very large and old subdivision of macrohaplogroup N) is also widely represented and accounts for the other 40% of Indian MtDNA. A very old and most important subdivision of it is haplogroup U that, while also present in West Eurasia, has several subclades specific to South Asia.

Most important South Asian haplogroups within R:[17]

Haplogroup U is a sub-haplogroup of macrohaplogroup R.[17] The distribution of haplogroup U is a mirror image of that for haplogroup M: the former has not been described so far among eastern Asians but is frequent in European populations as well as among Indians.[18] Indian U lineages differ substantially from those in Europe and their coalescence to a common ancestor also dates back to about 50,000 years.[1]

It is also found in SW Arabia.

It is also found in Oman.

The major Y chromosome DNA haplogroups in the subcontinent are Haplogroup F's descendant haplogroups R (mostly R1a1, R2 and R2a), L, H and J (mostly J2).[8]

The South Asian Y-chromosomal gene pool is characterized by five major lineages: R1a, R2, H, L and J2. Their geographical origins are listed as follows, according to the latest scholarship:

Haplogroup H (Y-DNA) is found at a high frequency in South Asia. H is rarely found outside of the South Asia but is common among the Romanis, particularly the H-M82 subgroup. Haplogroup H is frequently found among populations of India, Sri Lanka, Nepal, Pakistan and Maldives. All three branches of Haplogroup H (Y-DNA) are found in Indian-subcontinent.

It is a branch of Haplogroup F and descends from GHIJK family. Haplogroup H is believed to have arisen in South Asia between 30,000 and 40,000 years ago.[19] Its probable site of introduction is South Asia, since it is concentrated there. It seems to represent the main Y-Chromosome haplogroup of the paleolithic inhabitants of Indian-Subcontinent. Some individuals in South Asia have also been shown to belong to the much rarer subclade H3 (Z5857).[19] Haplogroup H is by no means restricted to specific populations. For example, H is possessed by about 28.8% of Indo-Aryan castes.[9][20] and in tribals about 25-35%.[11][20]

Haplogroup J2 reflects presence from neolithic period in the subcontinent.[21] The frequency of J2 is higher in South Indian castes (19%) than in North Indian castes (11%) or Pakistan (12%).[9]Haplogroup J2 frequency is higher among south Indian middle castes at 21%, followed by upper castes at 18.6%, and lower castes 14%.[9] J2 is present in tribals too and has a frequency of 11% in Austro-Asiatic tribals. Among the Austro-Asiatic tribals, the predominant J2 occurs in the Lodha(35%).[9] J2 is also present in the South Indian hill tribe Toda at a frequency of 38.46%[22] and in the Kol tribe of Uttar Pradesh at a frequency of 33.34%.[23] Haplogroup J-P209 was found to be more common in India's Shia Muslims, of which 28.7% belong to haplogroup J, with 13.7% in J-M410, 10.6% in J-M267 and 4.4% in J2b (Eaaswarkhanth 2009).

In Pakistan, the highest frequencies of J2-M172 were observed among the Parsis at 38.89%, the Dravidian speaking Brahui's at 28.18% and the Makrani Balochs at 24%.[24] It also occurs at 18.18% in Makrani Siddis and at 3% in Karnataka Siddis.[24][25]

J2-M172 is found at an overall frequency of 16.1% in the people of Sri Lanka.[26] In Maldives, 22% of Maldivian population were found to be haplogroup J2 positive.[citation needed]

Haplogroup L shows time of neolithic expansion.[21] The clade is present in the Indian population at an overall frequency of ca.7-15%.[9][11][27][20] There are three subbranches of Haplogroup L and all three are found mostly in South Asia. Haplogroup L has higher frequency among south Indian castes (ca. 17-19%) and reaches up to 68% in some castes in Karnataka but is somewhat rarer in north Indian castes (ca. 5-6%).[9][28] They make a case for an indigenous origin of L-M76 in South Asia as the spatial distributions of both L-M76 HG frequency and associated microsatellite variance show a pattern of spread emanating from southern India.[9] The presence of haplogroup L is quite rare among tribal groups (ca. 5,6-7%)[9][11][20]

Haplogroup L3 (M357) is found frequently among Burusho (approx. 12%[29]) and Pashtuns (approx. 7%[29]), Its highest frequency can be found in south western Balochistan province along the Makran coast (28%) to Indus River delta. L3a (PK3) is found in approximately 23% of Nuristani in northwest Pakistan,[29]

The clade is present in moderate distribution among the general Pakistani population (approx. 11.6%[29]).

In South Asia R1a1 has been observed often with high frequency in a number of demographic groups,[10][30][31] as well as with highest STR diversity which lead some to see it as the locus of origin.[32][33][34]

While R1a originated ca. 22,000[33] to 25,000 years ago, its subclade M417 (R1a1a1) diversified ca. 5,800 years ago. The distribution of M417-subclades R1-Z282 (including R1-Z280) in Central- and Eastern Europe and R1-Z93 in Asia suggests that R1a1a diversified within the Eurasian Steppes or the Middle East and Caucasus region. The place of origin of these subclades plays a role in the debate about the origins of Indo-Europeans.

In India, high percentage of this haplogroup is observed in West Bengal Brahmins (72%) [30] to the east, Konkanastha Brahmins (48%) [30] to the west, Khatris (67%)[31] in north, Iyengar Brahmins (31%) in the south.[30] It has also been found in several South Indian Dravidian-speaking Tribals including the Chenchu (26%)[32] and Valmikis of Andhra Pradesh as well as the Yadav and Kallar of Tamil Nadu suggesting that M17 is widespread in these Southern Indians tribes.[32] Besides these, studies show high percentages in regionally diverse groups such as Manipuris (50%) [31] to the extreme North East and in among Punjabis (47%)[32] to the extreme North West.

In Pakistan it is found at 71% among the Mohanna of Sindh Province to the south and 46% among the Baltis of Gilgit-Baltistan to the north.[31]

23% of the Sinhalese people out of a sample of 87 subjects were found to be R1a1a (R-SRY1532) positive according to a 2003 research.[32]

In Maldives, 24% of the Maldivian people were found to be R1a1a (M17) positive.[citation needed]

People in Terai Region, Nepal show R1a1a at 69%.[37]

In South Asia, the frequency of R2 and R2a lineage is around 10-15% in India and Sri Lanka and 7-8% in Pakistan. At least 90% of R-M124 individuals are located in the Indian sub-continent.[38] It is also reported in Caucasus and Central Asia at lower frequency.

Among regional groups, it is found among West Bengalis (23%), New Delhi Hindus (20%), Punjabis (5%) and Gujaratis (3%).[32] Among tribal groups, Karmalis of West Bengal showed highest at 100%[10] followed by Lodhas (43%)[39] to the east, while Bhil of Gujarat in the west were at 18%,[33]Tharus of north showed it at 17%,[4]Chenchu and Pallan of south were at 20% and 14% respectively.[10][9] Among caste groups, high percentages are shown by Jaunpur Kshatriyas (87%), Kamma Chaudhary (73%), Bihar Yadav (50%), Khandayat (46%)and Kallar (44%).[10]

It is also significantly high in many Brahmin groups including Punjabi Brahmins (25%), Bengali Brahmins (22%), Konkanastha Brahmins (20%), Chaturvedis (32%), Bhargavas (32%), Kashmiri Pandits (14%) and Lingayat Brahmins (30%).[33][12][4][10]

North Indian Muslims have a frequency of 19% (Sunni) and 13% (Shia),[12] while Dawoodi Bohra Muslim in the western state of Gujarat have a frequency of 16% and Mappla Muslims of South India have a frequency of 5%.[40]

The R2 haplogroup is found in 14% of the Burusho people.[29] Among the Hunza it is found at 18% while the Parsis show it at 20%. It is also found in the northeastern part of Afghanistan.[citation needed]

39% of the Sinhalese of Sri Lanka were found to be R2 positive according to a 2003 research.[32]

13% of the Maldivian people of Maldives are found to have R2[citation needed]

In Nepal, R2 percentages range from 2% to 26% within different groups under various studies. Newars show a significantly high frequency of 26% while people of Kathmandu show it at 10%.

The Indian Genome Variation Consortium (2008), divides the population of the subcontinent into four linguistic groups Indo-European, Dravidian, Tibeto-Burman and Austro-Asiatic.[41][42][43][45] The molecular anthropology studies use three different type of markers: Mitochondrial DNA (mtDNA) variation which is maternally inherited and highly polymorphic, Y Chromosome variation which involves uniparental transmission along the male lines, and Autosomal DNA variation.[4]:04

Most of the studies based on mtDNA variation have reported genetic unity of Indian populations across language, caste and tribal groups.[1][2][3] It is likely that haplogroup M was brought to Asia from East Africa along the southern route by earliest migration wave 60,000 years ago.[1]

According to Kivisild et al. (1999), "Minor overlaps with lineages described in other Eurasian populations clearly demonstrate that recent immigrations have had very little impact on the innate structure of the maternal gene pool of Indians. Despite the variations found within India, these populations stem from a limited number of founder lineages. These lineages were most likely introduced to the Indian subcontinent during the Middle Palaeolithic, before the peopling of Europe and perhaps the Old World in general."[1] Basu et al. (2003) also emphasizes underlying unity of female lineages in India.[27]

Conclusions based on Y Chromosome variation have been more varied than those based on mtDNA variation. While Kivisild et al. (2003) proposes an ancient and shared genetic heritage of male lineages in India, Bamshad et al. (2001) suggests an affinity between Indian male lineages and west Eurasians proportionate to caste rank and places caste populations of southern Indian states closer to East Europeans.[46]

Basu et al. (2003) concludes that AustroAsiatic tribal populations entered India first from the Northwest corridor and much later some of them through Northeastern corridor.[27] Whereas, Kumar et al. (2007) analyzed 25 Indian Austro-Asiatic tribes and found strong paternal genetic link among the sub-linguistic groups of the Indian Austro-Asiatic populations.[39] Mukherjee et al. (2001) places North Indians between west Asian and Central Asian populations,[47] whereas Cordaux et al. (2004) argues that the Indian caste populations are closer to Central Asian populations.[20] Sahoo et al. (2006) and Sengupata et al. (2006) suggest that Indian caste populations have not been subject to any recent admixtures.[9][10] Sanghamitra Sahoo concludes his study with:[10]

It is not necessary, based on the current evidence, to look beyond South Asia for the origins of the paternal heritage of the majority of Indians at the time of the onset of settled agriculture. The perennial concept of people, language, and agriculture arriving to India together through the northwest corridor does not hold up to close scrutiny. Recent claims for a linkage of haplogroups J2, L, R1a, and R2 with a contemporaneous origin for the majority of the Indian castes paternal lineages from outside the subcontinent are rejected, although our findings do support a local origin of haplogroups F* and H. Of the others, only J2 indicates an unambiguous recent external contribution, from West Asia rather than Central Asia. The current distributions of haplogroup frequencies are, with the exception of the lineages, predominantly driven by geographical, rather than cultural determinants. Ironically, it is in the northeast of India, among the TB groups that there is clear-cut evidence for large-scale demic diffusion traceable by genes, culture, and language, but apparently not by agriculture.

Results of studies based upon autosomal DNA variation have also been varied. In a major study (2009) using over 500,000 biallelic autosomal markers, Reich hypothesized that the modern Indian population was the result of admixture between two genetically divergent ancestral populations dating from the post-Holocene era. These two "reconstructed" ancient populations he termed "Ancestral South Indians" (ASI) and "Ancestral North Indians" (ANI). According to Reich: "ANI ancestry is significantly higher in Indo-European than Dravidian speakers, suggesting that the ancestral ASI may have spoken a Dravidian language before mixing with the ANI."[48]

Further building on Reich et al.'s characterization of the South Asian population as historically based on admixture of ANI (Ancestral North Indian) and ASI (Ancestral South Indian) populations, a 2013 paper by Moorjani et al. states that a major mixture between populations in India occurred 1,9004,200 years BP characterized by the deurbanization of the Indus civilization and population shift to the Gangetic system.[6]

Basu et al. (2003) suggests concludes that "Dravidian tribals were possibly widespread throughout India before the arrival of the Indo-European-speaking nomads" and that "formation of populations by fission that resulted in founder and drift effects have left their imprints on the genetic structures of contemporary populations".[27] The geneticist PP Majumder (2010) has recently argued that the findings of Reich et al. (2009) are in remarkable concordance with previous research using mtDNA and Y-DNA:[49]

Central Asian populations are supposed to have been major contributors to the Indian gene pool, particularly to the northern Indian gene pool, and the migrants had supposedly moved into India through what is now Afghanistan and Pakistan. Using mitochondrial DNA variation data collated from various studies, we have shown that populations of Central Asia and Pakistan show the lowest coefficient of genetic differentiation with the north Indian populations, a higher differentiation with the south Indian populations, and the highest with the northeast Indian populations. Northern Indian populations are genetically closer to Central Asians than populations of other geographical regions of India... . Consistent with the above findings, a recent study using over 500,000 biallelic autosomal markers has found a north to south gradient of genetic proximity of Indian populations to western Eurasians. This feature is likely related to the proportions of ancestry derived from the western Eurasian gene pool, which, as this study has shown, is greater in populations inhabiting northern India than those inhabiting southern India.

Studies by Watkins et al. (2005) and Kivisild et al. (2003) based on autosomal markers conclude that Indian caste and tribal populations have a common ancestry.[50][51] Reddy et al. (2005) found fairly uniform allele frequency distributions across caste groups of southern Andhra Pradesh, but significantly larger genetic distance between caste groups and tribes indicating genetic isolation of the tribes and castes.[52]

Viswanathan et al. (2004) in a study on genetic structure and affinities among tribal populations of southern India concludes, "Genetic differentiation was high and genetic distances were not significantly correlated with geographic distances. Genetic drift therefore probably played a significant role in shaping the patterns of genetic variation observed in southern Indian tribal populations. Otherwise, analyses of population relationships showed that all Indian and South Asian populations are still similar to one another, regardless of phenotypic characteristics, and do not show any particular affinities to Africans. We conclude that the phenotypic similarities of some Indian groups to Africans do not reflect a close relationship between these groups, but are better explained by convergence."[53]

A 2011 study published in the American Journal of Human Genetics[5] indicates that Indian ancestral components are the result of a more complex demographic history than was previously thought. According to the researchers, South Asia harbours two major ancestral components, one of which is spread at comparable frequency and genetic diversity in populations of Central Asia, West Asia and Europe; the other component is more restricted to South Asia. However, if one were to rule out the possibility of a large-scale Indo-Aryan migration, these findings suggest that the genetic affinities of both Indian ancestral components are the result of multiple gene flows over the course of thousands of years.[5]

Follow this link:
Genetics and archaeogenetics of South Asia - Wikipedia

PCAT bio: genetics – Biology None with Michelle at …

Log In Continue with Google Continue with Facebook

or

Dont have an account? Sign up

or

Sign up with Google or Facebook

or

Name

Email

Password

Birthday

To sign up you must be 13 or older. Other people wont see your birthday.

Month January February March April May June July August September October November December

Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Year

Get started today for free

Created: 2017-05-31 Last Modified: 2017-06-09

the basic unit of genetic material - a defined portion of a chromosome that encodes for a particular trait or substance such as hair color, blood type, etc.

the different forms a particular gene can occur in (e.g. brown, blue, green eyes) - you have two copies of each gene (one from mom and one from dad) so there are two potential alleles for each

codominant/incomplete dominace

neither masks the other so both are expressed (AB blood type)

the makeup of the genes - which 2 alleles are present

what actually gets expressed - what you "see"

type A- antigen on red blood cell's surface; type B - B antigen on surface; type AB - both A and B antigens on surface; type O - neither A or B antigen on surface

O is recessive - to have type O blood, an individual must be homozygous (OO); A is dominant- to have type A blood, an individual can be either (AA or AO); type B is also dominant - to have type B you can be either (BB or BO); AB blood has an AB genotype, because the genes are codominant.

in blood donations/transfusions, what will happen

you will react (produce antibodies) against the type(s) you don't have even without prior exposure

can receive from A or O, can donate to A or AB

can receive from B or O, can donate to B or AB

can receive from A, B, AB, or Ol can donate to AB

can receive from O; can donate to A, B, AB, or O

transfusion reactions with the Rh blood system

you will once again react (produce antibodies) against the type(s) / antigen(s) you don't have - in this case, Rh- individuals react against Rh+ cells but only after prior exposure

when an Rh- mother is carrying a Rh+ child. after she is exposed to Rh+ RBC's during the first pregnancy, she may produce IgG antibodies which will cross the placenta and attack deal RBC's in later pregnancies. this is known as hemolytic disease of the newborn or Rh disease

the most common x-inked disorder - a defect in clotting proteins (a recessive trait, designated by a small h)

when can males and females be considered hemopheliac

males - XhY; females XhXh. for females to have it, they have to have both X chromosomes with the h

most common form of color blindness

defect in the production of melanin

a change of a single nucleotide of the hemoglobin b gene (molecule that carries oxygen) - RBC's have typical sickle shape

phenylketonuria - a defect in the enzyme that normally converts Phe to Tyr leads to buildup of phenylalanine in the bloodstream and neurological problems

CF. enzyme defect causes the production of abnormal mucus which causes problems in both the respiratory and gastrointestinal tracts

what does the term autosomal recessive disorder refer to

you must have 2 copies of the bad gene in order for it to be expressed because the trait is on chromosomes other than the sex chromosomes. it must be recessive (cc). if its (Cc) you are a carrier of the gene but do not have the disorder

autosomal dominant disorders

because the gene is dominant, you only need one copy to have the disorder - therefore just one paren needs to have the gene/allele, not both - there are no "carriers"

an invariably fatal neurological disorder which does not show up until 30 or 40 years of age - after the person has had children and possibly passed the gene on

chromosomal and structural disorders general concepts

these involve physical or structural defects in the chromosomes rather than in the genes - they often result fro nondisjunction, where one or more chromosome pairs do not separate during mitosis or meiosis - this leads to cells having too many or too few chromosomes due to unequal distribution during cell division

refers to more than the usual amount of a particular chromosome

also known as trisomy 21 due to the fact that there are 3 copies of that chromosome rather than 2 - associated with structural defects of the face and neurological problems. other examples are XXY (Klinefelter syndrome) or XYY

only one copy of the chromosomes - an example is women with only one X chromosome (turners syndrome)

Dan is a nucleic acid - composed of 4 bases or nucleotides - A, G, C, and T. the three main components of a nucleotide are a 5-carbon sugar, a nitrogenous base (purine or pyrimidine) and a phosphate group

the two strands of DNA are connected by hydrogen bonding between bases in the two strands. known as base pairing. A only pairs with T and G only pairs with C.

the two strands of DNA form a ...

a DNA sequence that triggers gene expression/ transcription

what is the difference in base pairing with RNA vs. DNA

in RNA there is U (uracil) instead of T, so the pairing is A-U and G-C

the initial step is the splitting of the two strand to form a replication fork - it involves helices enzymes - each single stranded DNA will then serve as the template for the synthesis of a complementary (not identical) new strand (e.g. where there is a G in the old strand there will be a C in the new strand). The enzyme primarily responsible for this process is DNA polymerase - gaps in the lagging DNA strand are joined by DNA ligase. DNA polymerase (along with a target specific primer and heat) is a key part of a testing procedure known as the Polymerase Chain reaction (PCR) which can amplify small amount of DNA or RNA being looked for

one strand of the DNA molecule is read to produce RNA - transcription. the mRNA attaches to ribosomes to trigger the production of protein (translation) - the condons in the mRNA are "read" by transfer RNA (tRNA) to place the appropriate amino acids in their place

a DNA sequence that triggers gene expression/transcription

are a cluster of genes controlled by a single promoter (the lac operon is often used as an example of this)

refers to a permanent change in the structure of the DNA which is passed on to the offspring of the effected cell - it may or n=may not have a xnoticebaleeffect and the effect may be either helpful or harmful

a single base is changed - this leads to a change in the codon ( e.g. UGC --> UGG) which in turn leads to the production of a different amino acid. the "sense" or meaning of the codon has been changed. a change in the first two of the three letters in a codon will have the greatest impact

a single base is changed. this leads to a change in the codon (e.g. UAG, UAC) so that it becomes a stop codon which terminates the synthesis of the protein at that point in the mRNA instead of at the real end of the protein - how near this is to the start or end of the message determines its impact

the way the codons in the mRNA are read is messed up by adding or removing bases (the location of this change determines its impact - the closer it is to the start of the message, the more harmful it will be )

an extra base is inserted into the DNA molecule - this throws off the codon it ends up in and also all those "downstream" from that point (a major change)

in this case a base is deleted from the DNA molecule - this again throws off the codon it ends up in and also all those "downstream" from that point (a major change)

refers to the transfer of genetic information from one organism (the donor) to another (the recipient)

bacteria take up DNA from their surroundings through the cell wall of the recipient bacteria and integrated into its own DNA - this can also be done in the laboratory

involves transfer of a small piece of DNA (a plasmid) or possibly chromosomal DNA from one bacteria to another that is connected by a sex pilus - the donor bacteria are designated F+ of Hfr and the recipient bacteria F - ; antibiotic resistance and other genes can be transferred this way

a virus (bacteriophage) carries genetic information from one bacteria to another

transposable genetic elements - aka "jumping genes" - genetic elements that move from one place to another within a chromosome

* The material on this site is created by StudyBlue users. StudyBlue is not affiliated with, sponsored by or endorsed by the academic institution or instructor.

"StudyBlue is great for studying. I love the study guides, flashcards, and quizzes. So extremely helpful for all of my classes!"

Alice, Arizona State University

"I'm a student using StudyBlue, and I can 100% say that it helps me so much. Study materials for almost every subject in school are available in StudyBlue. It is so helpful for my education!"

Tim, University of Florida

"StudyBlue provides way more features than other studying apps, and thus allows me to learn very quickly! I actually feel much more comfortable taking my exams after I study with this app. It's amazing!"

Jennifer, Rutgers University

"I love flashcards but carrying around physical flashcards is cumbersome and simply outdated. StudyBlue is exactly what I was looking for!"

Justin, LSU

* The material on this site is created by StudyBlue users. StudyBlue is not affiliated with, sponsored by or endorsed by the academic institution or instructor.

More:
PCAT bio: genetics - Biology None with Michelle at ...

Clinical Cancer Genetics and Prevention Johns Hopkins …

Posted: June 9, 2017 at 4:48 pm

Johns Hopkins is a leader regarding thegenetics of cancer. Research in genetics,discoveredby Bert Vogelstein here at Johns Hopkins in 1983, has lead they way in discoveriesthroughout the country. Our experts in basic sciences, public health offer a wealth of expertiese for patients at a high risk of cancer.

At The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, we offer specifically designed programs to meet the needs of high-risk patients and families lead by Kala Visvanathan, M.D. This knowledge can help the person or families in planning health care for the future. Individuals assessed to have a higher than average risk of cancer will be referred to a specialist. They can talk to the person about having screening early to detect any signs of cancer as early as possible to ensure prompt treatment and successful outcomes.

The Clinical Cancer Genetics Program offers risk assessment, testing and long term management for men and women with a family history of cancer. The program is composed of three clinics:

See the article here: Clinical Cancer Genetics and Prevention Johns Hopkins

Read this article:
Clinical Cancer Genetics and Prevention Johns Hopkins ...

Genetics / Genomics SciPol Daily, 9 June 2017 | SciPol

Clinical OMICs Jackson Laboratory Expands Genomic Research Into China

The Jackson Laboratory (JAX) said it will expand into China through a strategic collaborative clinical genomics research agreement with three groups in Wenzhou. JAX will collaborate with the Wenzhou Municipal People's Government, Ouhai District People's Government (WZ), and Wenzhou Medical University and its affiliated hospitals (WMU), to conduct research on the genomic causes of disease.

Medical Xpress Stem cell treatment for lethal STAT1 gene mutation produces mixed results

Researchers report the first-ever study assessing how patients with "gain of function" mutation of the STAT1 gene respond to stem cell transplantation. It involved 15 young patients from nine different countries, each suffering a range of complications caused by the gene's mutation. Of these, only six survived a regime of stem cell transplantationwith five completely cured and disease free by the study's conclusion.

Motherboard CRISPR Is Not Accurate Enough to Save Us Yet

While this study brings some CRISPR limitations to the forefront, all of its claims may not stand up under scrutiny. We're definitely going to need more research to really figure out the extent of off-target mutations, when they happen, and why.

See the rest here:
Genetics / Genomics SciPol Daily, 9 June 2017 | SciPol

NewLink Genetics’ stock plunges as Genentech plans to returns rights cancer treatment candidate – MarketWatch

Shares of NewLink Genetics Corp. NLNK, +3.53% plunged 31% in premarket trade Thursday, putting them on track to open at a more-than 5-year low, after the biopharmaceutical company said Genentech planned to return the the rights to NewLink's IDO inhibitor GDC-0919 (navoximod), an immuno-oncology product candidate. The rights were part of a license agreement from October 2014. NewLink said the research collaboration with Genentech, a member of the Roche Group ROG, +0.12% for the discovery of IDO/TDO inhibitors will continue. "We are obviously disappointed in this decision," said NewLink Chief Executive Charles Link. "We remain committed to advancing our IDO pathway inhibitor indoximod, which continues to generate exciting data in combination with anti-PD-1 agents, cancer vaccines, and chemotherapy in multiple cancer types including melanoma, prostate cancer, acute myeloid leukemia, and pancreatic cancer." NewLink shares had tumbled in April after disappointing results of a trial in which indoximod was being tested in combination with Merck & Co.'s MRK, +1.88% Keytruda. The stock traded at $7.38 ahead of the open, the lowest price seen during regular trading hours since February 2012. The stock has plummeted 47% over the past three months, while the iShares Nasdaq Biotechnology ETF IBB, -0.22% has slipped 1.6% and the S&P 500 SPX, -0.08% has gained 8.7%.

See more here:
NewLink Genetics' stock plunges as Genentech plans to returns rights cancer treatment candidate - MarketWatch

Canada Is Using Genetics to Make Cows Less Gassy – WIRED

Number 1995 is a very special cow. Every day, this Holstein, mostly black with a white cat-face-shaped spot on her forehead, sticks her head into a trough that measures the exact amount of feed she eats. Shes had her genome partially sequenced, and will soon get her breath checked for methane several times a day.

Number 1995 also happens to be J. P. Brouwers favorite. I just like her character, the Canadian farmer says. It has nothing to do with how she looks. Shes a nice cow.

Brouwer, along with his father and two brothers at Sunalta Farms in central Alberta, runs the first commercial dairy farm contributing data to the Genome Canada project. One part of the project aims to increase feed efficiencygrowing cows as big as possible with as little food as possibleand reduce emissions of methane, a greenhouse gas that traps 30 times more heat per molecule than carbon dioxide. Eight years after scientists from the National Institutes of Health and the US Department of Agriculture sequenced the first cow genome , this project is trying to turn that information into more profitable, environmentally friendly cattle. Theyll be like Number 1995, but better.

Bovine livestock are responsible for about 9.5 percent of global greenhouse gas output, according to the Food and Agriculture Organization of the United Nations. Farmers are trying to reduce those emissions with lots of different strategies, starting with their diets. Researchers have tried adding flaxseed oil , garlic, juniper berries , and even seaweed to cow feed. Some scientists at Pennsylvania State University are even genetically modifying the bacteria in cow guts. Simpler tweaks can have an impact, too: Vaccinating cows against common viruses mean fewer cows die, letting farmers focus on raising fewer, healthier cows that live long into adulthoodcreating less methane as a result.

But scientists are also tweaking the cows themselves. The Genome Canada project, led by Filippo Miglior at the University of Guelph and Paul Stothard at the University of Alberta, harnesses labs in the US, UK, Denmark, Australia, and Switzerland to help identify cows that produce fewer greenhouse gases, with the ultimate goal of distributing the responsible genesconveniently transported in the form of bull semento areas that dont have the resources to develop their own greener cows.

Oliver Milman

How Can California Cut Methane Emissions if Cows Keep Cutting the Cheese?

Sarah Zhang

Farmers Are Manipulating Microbiomes to Help Crops Grow

Wired Staff

Origin of Modern Cows Traced to Single Herd

1995 is one of at least 10,000 cows that will be involved in the project, including those from two Canadian research farms, three Canadian commercial farms, and genome data from Migliors international allies. 1995s farmer, Brouwer, sent a little of her hair to a genome sequencing labin Canada, the farmers use Genome Quebec in Montreal, and every other country has an equivalent lab. These scientists fully sequence each bull, which costs about $1,100. A partial sequence like 1995s costs much less at about $40, but shell get a full sequence if she happens to have remarkable methane emissions and feed efficiency. We are going to try to identify the cows that do great and the cows that do poorly, says Miglior.

Its not easy to gather data on how much methane a cow actually produces: You can stick a cow in a closed chamber for a few days, but thats expensive and interrupts the cows daily routine. Some researchers use small backpacks that wrap around a cows head and measure how much methane it exhales. Migliors lab in Ontarioalong with the other farms involved in the projectuse a third option: a machine that puts out little cow snacks. Cows like Number 1995 stop by a couple of times a day to take a nibble. When the animal sticks its head in the machine, a vent sucks up a sample of its breath and measures the amount of methane and carbon dioxide.

That methane data is hard-won, and it wasnt easy for Miglior to get cattle researchers to share. But Yvette de Haas , a senior scientist with Wageningen Livestock Research in the Netherlands who is collaborating with Miglior, was won over by the promise of the work. Together, we knew more than each of us individually, she says. And the research could ultimately benefit ranchers and dairy farmers all over the world, not just in the developed countries where the research is taking place.

Once all the data is collected, Migliors labsupported by from the Canadian federal government, the Ontario and Alberta equivalents of the US state government, and dairy industry partnersworks to identify specific genetic markers associated with these traits. Finally, he makes recommendations to the farmers that breed the bulls to provide semen for the dairy cows. We can identify the best young bulls that carry the right markers for their particular traits, says Miglior. The best genes keep on accumulating.

Miglior says he considers over 80 other traits while making his recommendationsnot just feed efficiency and methane production, but also overall health. I want a cow to live a long, awesome and producing life, says Brouwer. Thats every farmers goal.

Another goal, of course, is making money. Brouwer thinks his participation in the genetics research will give him a leg up over his fellow dairy farmers. We would like to see cows with less potential leave the herd, he says. You want to keep the bestthats how you move forward. Once this project starts returning data, Brouwer will know which cows are most efficient, and can sell off the ones that would grow more slowly and produce more methane.

These changes will not happen overnight. Breeding, especially in livestock, is a long-term perspective, says de Haas. I cant change it from today to tomorrow, but I can change it in five years time. Miglior plans to monitor 1995who loves cuddling Brouwer when shes not snacking in her methane-measuring troughuntil at least 2019. If her genes turn out to be as exceptional as her personality, they might end up in Holsteins for many generations to come.

More:
Canada Is Using Genetics to Make Cows Less Gassy - WIRED

101-year-old woman credits genetics, being happy as keys to longevity – Sentinel-Tribune

Photo by J.D. Pooley/Sentinel-Tribune

Mary Frazier is 101 and lives at Grand Rapids Care Center in Grand Rapids.

Posted: Saturday, June 10, 2017 12:31 am

101-year-old woman credits genetics, being happy as keys to longevity By SARAH BAER, Sentinel-Tribune Staff Writer Sentinel-Tribune

GRAND RAPIDS -- Mary Frazier is turning 101 years old on Sunday and it is going to be a big celebration at Grand Rapids Care Center.

Jenn Wanless, director of the center, said that on Frazier's birthday they are going to have a luncheon with all of Frazier's family, and her closest friends along with the residents and staff. The meal provided will be many of Frazier's favorite foods, including meatloaf, scallop potatoes and pie.

Your current subscription does not provide access to this content. Please click the button below to manage your account.

kAmQ|2CJ 😀 2 52C=:?8 =25J H9@ =@G6D 3:?8@ 2?5 😀 G6CJ H6== :DD 2 362E[Q (2?=6DD D2:5]k^Am

kAmuC2K:6C 2EEC:3FE6D 96C DEC@?8 >:?5 2?5 >2?J 3:CE952JD E@ 96C A2C6?EDV 86?6E:4D 2?5 2=D@ E@ 36:?8 92AAJ]k^Am

kAmuC2K:6C 3682? E6249:?8 2E !C@G:56?46 %@H?D9:A[ H96C6 D96 H2D E96 7:CDE <:?56C82CE6? E62496C 2E vC2?5 #2A:5D]k^Am

kAmuC2K:6C 925 D92C65 E92E E6249:?8 <:?56C82CE6? H2D @?6 @7 96C 7@?56DE >6>@C:6D[ 2=@?8 H:E9 A=2J:?8 32D<6E32== H9:=6 D96 H2D 8C@H:?8 FA]k^Am

kAm$96 7:?5D ;@J ?@H 😕

kAmQx 42?VE 36=:6G6 :EVD ECF6] xV> D@ E92?<7F=[ D@ G6CJ[ G6CJ E92?<7F=[Q uC2K:6C D2:5 H96? 2D<65 9@H D96 766=D 23@FE EFC?:?8 `_` E9:D >@?E9]k^Am

Your current subscription does not provide access to this content. Please click the button below to manage your account.

Posted in Front Page on Saturday, June 10, 2017 12:31 am.

Excerpt from:
101-year-old woman credits genetics, being happy as keys to longevity - Sentinel-Tribune

New issue: Pig Progress focuses on biosecurity and genetics – Pig Progress (registration) (blog)

Subjects related to biosecurity as well as breeding/genetics constitute the core of the latest print edition of Pig Progress.

The cover article is aptly titled Will Big Data change the future of pig genetics? and aims to answer this main question. Seeing that Big Data are making way in all sectors of pig production, genetics is no exception.

In fact, author and pig genetics expert Benny van Haandel argues, the developments are happening right now. Increasingly more data are becoming available as it costs increasingly less to gather them and more techniques become available every day. Analysing them properly will take pig production to a next level. Page 24

Illustration: Shutterstock | blackdogvfx

Years ago, studies were carried out on the techniques which could ensure the gender of pigs being born. This concept has been revived by developments in the United States, where sex-sorted sperm was introduced as a concept first in cattle and this has now been extended into the swine business.

Are we heading towards a future with female finishers only? Correspondent Treena Hein reports on page 22.

A lot has been said about internal and external biosecurity. Internal biosecurity means that inside pig farms every protocol is followed and that farm staff are aware how pathogens may travel within a farm. As P.H. Rathkjen and Xavier de Paz, Boehringer Ingelheim, describe, several apps might be useful. Page 12

A pig producer cleaning out a pig facility. Not only internal biosecurity, but also external biosecurity is important to avoid pathogens from coming in.

For a reliable outcome of pig nutrition research, sometimes it is needed to know how feed transforms during digestion. Cannulating pigs is a way to tap some semi-digested feed from a pigs gastro-intestinal tract without having to cull the animal. At Novus farm Green Acres in Missouri, they have a range of cannulated animals. Pig Progress editor Vincent ter Beek captured their story. Page 20

How can the digestibility of amino acids be enhanced? At Dupont Animal Nutrition, they believe the combination of an enzyme and a probiotic has great possibilities. Scientist Laura Payling and swine platform lead Maria Walsh explain how exactly. Page 34

A potential zinc ban is keeping many authors busy these days including columnist John Gadd. He wonders what producers can do to alleviate a potential ZnO ban on page 9. In addition, welfare columnist Dr Monique Pairis-Garcia takes a closer look at loose house farrowing options for sows. Page 34

Landlocked yet insular in a way, that holds true for Switzerland. The country asks more and different things from its pig production chain than in the surrounding EU and therefore the countrys pig industry has its own dynamics. Which? Read Maarten Ceyssens contribution on page 10.

At Scotlands Rural College, Edinburgh, UK, much effort has been spent on aggression issues among pigs over 15 years. How does it originate, what are the consequences for pig farmers, and what can they do about it? Researcher Dr Irene Camerlink presents a useful summary as from page 6.

Aggression by two pigs as photographed during the trials. Photo: Marianne Farish

Every year, the worlds feed production is growing and so is the pig segment of that. Animal nutrition company Alltech summarised it in its annual overview; editor Emmy Koeleman of All About Feed made a concise summary. Page 14

Emmy Koeleman also interviewed Sren Bank, the chief commercial officer of Hamlet Protein. He explains the companys focus on young animal nutrition. Page 16

Sows do suffer from high temperatures and thus these may prove to be detrimental for their production performance. Animal nutrition company Lallemand shares some of their latest insights on how nutritional solutions can alleviate that. Page 27

To read all the articles in this issue, go to the magazine overview page and sign up with your current website login.

See the original post:
New issue: Pig Progress focuses on biosecurity and genetics - Pig Progress (registration) (blog)

Why Is NewLink Genetics Losing One-Third of Its Value Today? – Motley Fool

What happened

After a surprising decision by Roche Holding (NASDAQOTH:RHHBY) to exit its co-development deal on a new cancer drug, NewLink Genetics Corporation (NASDAQ:NLNK) shares were crashing 32% as of 1 p.m. EDT.

Hope that success for NewLink Genetics' IDO-inhibiting cancer drugs could get its share price back on track, following a disappointing trial failure last year, were dashed today when Roche announced it was returning rights to co-develop GDC-0919.

IMAGE SOURCE: GETTY IMAGES.

The news is a bit surprising given that Roche just presented data from a trial of GDC-0919 at the high-profile American Society of Clinical Oncology (ASCO) annual meeting this week.

However, it becomes a little less surprising when we dig into the data and discover that the benefit of adding GDC-0919 to Roche's PD-L1 checkpoint inhibitor Tecentriq didn't move the needle much. The combination did improve response rates, but the improvement appears too slight for Roche to justify committing any more research to it. Specifically, the overall response rate in patients diagnosed with various solid tumor cancers was only 9%, and all responses were partial responses.

Further sealing GDC-0919's fate was that the response rate appears to trail that of Incyte's (NASDAQ:INCY) epacadostat, a drug that has the same IDO-inhibiting target as GDC-0919. At ASCO, Incyte reported that teaming epacadostat up with Merck & Co.'s (NYSE:MRK) PD-1 checkpoint inhibitor Keytruda delivered overall response rates of 30% to 35% in various cancers, including kidney cancer and non-small cell lung cancer.

Roche's decision caps off a week of disappointing news at NewLink Genetics. On Jun. 2, it reported that another of its IDO-inhibitors, indoximod, failed a mid-stage breast cancer trial, casting doubt on its use in indications outside of melanoma, where results have been solid.

In April, management said that combining indoximod with Keytruda resulted in an objective response rate of 52%, and a disease control rate of 73%. Those are good numbers, but they don't appear to be much different from epacadostat, which delivered a 58% overall response rate in advanced melanoma patients when used alongside Keytruda, and a 74% disease-control rate.

Overall, IDO-inhibitors appear to work, but their efficacy might not be as strong across all cancers as hoped; undeniably, that puts peak sales forecasts for this class of drugs at risk. Only time will tell what NewLink Genetics does now that it has 100% rights to both indoximod and GDC-0919, but it may be a bit premature to assume that the company's IDO-inhibitors won't eventually make it to market.

Todd Campbell has no position in any stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Original post:
Why Is NewLink Genetics Losing One-Third of Its Value Today? - Motley Fool